{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:42:47Z","timestamp":1780522967602,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Left ventricular assist device (LVAD) therapy has evolved from a short-term bridge-to-transplant strategy into a long-term and often chronic therapy due to long waiting times for heart transplantation and application as destination therapy. Consequently, patients are at risk of developing complications necessitating LVAD exchange. The aim of this study is to assess patient outcomes after LVAD exchange.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Patients who underwent LVAD exchange between January 2010 and December 2022 were included. Logistic and cox regression analyses were used to identify potential risk factors for short and long-term adverse events, respectively. Survival after exchange was assessed using Kaplan\u2013Meier estimates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Sixty-one patients underwent a total of 80 LVAD exchanges. Most frequently observed short-term complications were pulmonary infections (16.3%) and right heart failure (16.3%). Exit-site infections (34.7%) and device malfunctions (25.3%) were the most often observed long-term complications. HeartWare ventricular assist device as index device was associated with a higher risk of right heart failure [hazard ratio 6.42, 95% confidence interval (CI) 1.80\u201322.90] and respiratory failure (hazard ratio 7.81, 95% CI 1.95\u201331.23) compared to HeartMate II and HeartMate 3. Survival was 83% (95% CI 75.5\u201395.3%) at 1 year and 67% (95% CI 53.9\u201384.7%) at 6 years after exchange. After 5 years, 25.0% was transplanted, 23.8% had undergone a re-exchange and 32.5% was alive without new intervention.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Although LVAD exchange can be performed with a relatively low mortality, other post-operative adverse events are common. Patients with the HeartWare ventricular assist device as index device may be at higher risk of developing right heart failure and respiratory failure after exchange.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezae317","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T23:34:13Z","timestamp":1725579253000},"source":"Crossref","is-referenced-by-count":3,"title":["Outcome after left ventricular assist device exchange"],"prefix":"10.1093","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7601-2801","authenticated-orcid":false,"given":"Jaiel","family":"Niamat","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Ramjankhan","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Van Der Kaaij","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gianoli","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda W","family":"Van Laake","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4518-4332","authenticated-orcid":false,"given":"Mostafa M","family":"Mokhles","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Medical Center Utrecht , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2024101722070446700_ezae317-B1","first-page":"1110","article-title":"Left ventricular assist devices as a bridge to cardiac transplantation","volume":"6","author":"Holley","year":"2014","journal-title":"J Thorac Dis"},{"key":"2024101722070446700_ezae317-B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtcvs.2004.04.044","article-title":"Left ventricular assist devices as destination therapy: a new look at survival","volume":"129","author":"Park","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024101722070446700_ezae317-B3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device\u2014final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"2024101722070446700_ezae317-B4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"2024101722070446700_ezae317-B5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"2024101722070446700_ezae317-B6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12471-021-01627-x","article-title":"Listing criteria for heart transplantation in the Netherlands","volume":"29","author":"de Jonge","year":"2021","journal-title":"Neth Heart J"},{"key":"2024101722070446700_ezae317-B7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.healun.2021.07.011","article-title":"Long-term survival on LVAD support: device complications and end-organ dysfunction limit long-term success","volume":"41","author":"Hariri","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2024101722070446700_ezae317-B8","doi-asserted-by":"crossref","first-page":"e005094","DOI":"10.1161\/CIRCHEARTFAILURE.118.005094","article-title":"Optimal hemodynamics during left ventricular assist device support are associated with reduced readmission rates","volume":"12","author":"Imamura","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2024101722070446700_ezae317-B9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.healun.2017.05.008","article-title":"Bleeding and thrombosis associated with ventricular assist device therapy","volume":"36","author":"Shah","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2024101722070446700_ezae317-B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0391398819876293","article-title":"Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange","volume":"43","author":"Urban","year":"2020","journal-title":"Int J Artif Organs"},{"key":"2024101722070446700_ezae317-B11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtcvs.2014.08.054","article-title":"Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure","volume":"149","author":"Anand","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024101722070446700_ezae317-B12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/aor.13594","article-title":"Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis","volume":"44","author":"Koda","year":"2020","journal-title":"Artif Organs"},{"key":"2024101722070446700_ezae317-B13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.healun.2013.07.003","article-title":"Continuous-flow left ventricular assist device exchange: clinical outcomes","volume":"33","author":"Ota","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2024101722070446700_ezae317-B14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2012.08.031","article-title":"Device exchange after primary left ventricular assist device implantation: indications and outcomes","volume":"95","author":"Stulak","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2024101722070446700_ezae317-B15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.athoracsur.2019.05.038","article-title":"Impact of left ventricular assist device exchange on outcomes after heart transplantation","volume":"109","author":"Suarez-Pierre","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2024101722070446700_ezae317-B16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MAT.0000000000001287","article-title":"Outcomes following left ventricular assist device exchange: focus on the impacts of device infection","volume":"67","author":"Yost","year":"2021","journal-title":"ASAIO J"},{"key":"2024101722070446700_ezae317-B17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MAT.0000000000000928","article-title":"Outcomes of repeat left ventricular assist device exchange","volume":"66","author":"Chou","year":"2020","journal-title":"ASAIO J"},{"key":"2024101722070446700_ezae317-B18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/icvts\/ivy102","article-title":"Statistical primer: how to deal with missing data in scientific research?","volume":"27","author":"Papageorgiou","year":"2018","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024101722070446700_ezae317-B19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/aor.14651","article-title":"Long-term predictors of morbidity and mortality in patients following LVAD replacement","volume":"48","author":"Jimenez Contreras","year":"2024","journal-title":"Artif Organs"},{"key":"2024101722070446700_ezae317-B20","first-page":"646","article-title":"Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3\u2122","volume":"62","author":"Hanke","year":"2021","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2024101722070446700_ezae317-B21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/03913988221088614","article-title":"C-reactive protein predicts early clinical outcomes and long-term mortality after left ventricular assisted device","volume":"45","author":"Tie","year":"2022","journal-title":"Int J Artif Organs"},{"key":"2024101722070446700_ezae317-B22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/MAT.0000000000001327","article-title":"C-reactive protein levels predict outcomes in continuous-flow left ventricular assist device patients: an intermacs analysis","volume":"67","author":"Batra","year":"2021","journal-title":"ASAIO J"},{"key":"2024101722070446700_ezae317-B23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MAT.0000000000001088","article-title":"Right ventricular failure post-implantation of left ventricular assist device: prevalence, pathophysiology, and predictors","volume":"66","author":"Ali","year":"2020","journal-title":"ASAIO J"},{"key":"2024101722070446700_ezae317-B24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0022-5223(96)70276-3","article-title":"Effects of failure of the right side of the heart and increased pulmonary resistance on mechanical circulatory support with use of the miniaturized HIA-VAD displacement pump system","volume":"112","author":"Waldenberger","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024101722070446700_ezae317-B25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.healun.2016.01.1225","article-title":"Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: a multi-center hemodynamic analysis","volume":"35","author":"Houston","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024101722070446700_ezae317-B26","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ehf2.13267","article-title":"Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support","volume":"8","author":"Numan","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024101722070446700_ezae317-B27","doi-asserted-by":"crossref","first-page":"e006369","DOI":"10.1161\/CIRCHEARTFAILURE.119.006369","article-title":"Clinical implications of respiratory failure in patients receiving durable left ventricular assist devices for end-stage heart failure","volume":"12","author":"Miller","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2024101722070446700_ezae317-B28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cardfail.2021.01.018","article-title":"Association between respiratory failure and clinical outcomes in patients with acute heart failure: analysis of 5 pooled clinical trials","volume":"27","author":"Miller","year":"2021","journal-title":"J Card Fail"},{"key":"2024101722070446700_ezae317-B29","author":"Administration USFaD","year":"2021"},{"key":"2024101722070446700_ezae317-B30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jtcvs.2021.11.085","article-title":"HVAD to HeartMate 3 left ventricular assist device exchange: best practices recommendations","volume":"163","author":"Salerno","year":"2022","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezae317\/59027750\/ezae317.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/66\/4\/ezae317\/59835363\/ezae317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/66\/4\/ezae317\/59835363\/ezae317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:07:50Z","timestamp":1729202870000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezae317\/7749866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezae317","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,5]]},"article-number":"ezae317"}}